Human LPL (Lipoprotein lipase) knockout HeLa cell lysate

Products

ace

Inquiry

ace

* First Name
* Last Name
* Business Email
Phone
Company/Institution
Job Title
* Services or Products of Interest (DCL-001096) Human LPL (Lipoprotein lipase) knockout HeLa cell lysate
When do you expect your project to start?
Project Description
* All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
* Tick to confirm the Research Use Only (RUO) statement.

Human LPL (Lipoprotein lipase) knockout HeLa cell lysate

Inquiry

Cat. No.: DCL-001096

Size: 1 mg Size: Customer Size

Product Information
Parental	HeLa
Organism	Human
Tissue	Cervix
Target Name	LPL
Cell Type	Epithelial cells
Gender	Female
UniProt No.	P06858
Gene ID	4023
Gene Description	The primary function of this lipase is the hydrolysis of triglycerides of circulating chylomicrons and very low density lipoproteins (VLDL). Binding to heparin sulfate proteogylcans at the cell surface is vital to the function. The apolipoprotein, APOC2, acts as a coactivator of LPL activity in the presence of lipids on the luminal surface of vascular endothelium.
Format	Frozen

Shipping & Storage
Shipping	Cryopreserved on dry ice.
Storage Instructions	Store at -80 °C. Please refer to protocols.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links

Contact Info

Copyright © Ace Therapeutics. All Rights Reserved.

Top